Sangamo Therapeutics
Clinical trials sponsored by Sangamo Therapeutics, explained in plain language.
-
Scientists track patients for 15 years after groundbreaking transplant cell therapy
Disease control OngoingThis study is tracking the long-term safety of an experimental cell therapy given to kidney transplant patients. Researchers are following 11 patients for up to 15 years to see if the treatment, designed to help the body accept the new organ, causes any unexpected health problems…
Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 06:36 UTC
-
15-Year watch: tracking gene Therapy's lasting impact on blood disorders
Disease control OngoingThis study is tracking the long-term safety and effectiveness of two gene therapies (BIVV003 and ST-400) for up to 15 years. It follows 8 people who have already received these treatments for severe sickle cell disease or transfusion-dependent beta-thalassemia. The main goal is t…
Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC